Answers are grounded in this paper and cite their sources.
Cross-sectional study finds diabetes and metabolic comorbidities associate with cefalexin selection in women with uncomplicated UTIs, indicating clinical patterns shaping antibiotic choices.
Urinary tract infections (UTIs) are a major reason for antibiotic prescribing in women worldwide. In low-resource settings, little is known about how patient comorbidity profiles influence antibiotic prescribing in primary care. We conducted a retrospective cross-sectional study of 510 adult women with clinician-documented uncomplicated UTIs (January–June 2024) at a primary care clinic in Zanjan, Iran. Antibiotics were grouped as cefalexin, other first-line agents (nitrofurantoin, trimethoprim-sulfamethoxazole), amoxicillin, or other antibiotics. Multinomial logistic regression was the primary analysis. Model 1 included individual comorbidities; Model 2 included a composite variable (≥ 2 metabolic comorbidities: diabetes, hypertension, dyslipidemia). Mean age was 48.5 (± 14.9) years; 72.2% had at least one comorbidity. Cefalexin was the most prescribed antibiotic (54.3%). In multinomial analysis (with results transformed to present odds of receiving cefalexin relative to each comparator), diabetes was significantly associated with cefalexin prescribing compared to other first-line agents (aOR 3.1, 95% CI 2.0–4.8, p < 0.001), amoxicillin (aOR 2.9, 95% CI 1.3–6.7, p = 0.010), and other antibiotics (aOR 2.8, 95% CI 1.6–5.0, p < 0.001). Age ≥ 60 years was also significantly associated with cefalexin prescribing compared to other first-line agents (aOR 2.1, 95% CI 1.5–3.1, p < 0.001), but not with other antibiotics (aOR 1.7, 95% CI 0.9–3.2, p = 0.085). The composite variable of ≥ 2 metabolic comorbidities was similarly associated (aOR 2.7, 95% CI 1.8–4.2, p < 0.001). Diabetes and metabolic comorbidity clusters are descriptively associated with cefalexin prescribing in this Iranian primary care setting. These findings are hypothesis-generating and should not be interpreted causally. Prospective studies with comprehensive clinical and microbiological data are needed before any practice recommendations can be made.
No takes yet. Share an insight, caveat, or question.
Alijaniha et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: